The Prometheus® device for extracorporeal support of combined liver and renal failure

Blood Purification

Volumn 23, Issue 4, 2005, Pages 298-302

  Rifai, Kinan ^a   Ernst, Thomas ^a   Kretschmer, Ulrich ^a   Hafer, Carsten ^a   Haller, Hermann ^a   Manns, Michael Peter ^a   Fliser, Danilo ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Artificial liver support; Fractionated plasma separation and adsorption; Hepatorenal syndrome; Liver failure; Prometheus ; Renal failure

Indexed keywords

ALBUMIN; AMMONIA; BILE ACID; BILIRUBIN GLUCURONIDE; CREATININE; WATER; SERUM ALBUMIN;

ADSORPTION; ADULT; AMMONIA BLOOD LEVEL; ARTICLE; ARTIFICIAL LIVER; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD PH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DETOXIFICATION; FEMALE; HEMODIALYSIS; HEPATORENAL SYNDROME; HUMAN; KIDNEY FAILURE; LIVER; LIVER FAILURE; MALE; PARAMETER; PRIORITY JOURNAL; SAFETY; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; SURVIVAL; UREA BLOOD LEVEL; BLOOD ANALYSIS; EXTRACORPOREAL CIRCULATION; INSTRUMENTATION; ISOLATION AND PURIFICATION;

BLOOD CHEMICAL ANALYSIS; EXTRACORPOREAL CIRCULATION; FEMALE; HEPATORENAL SYNDROME; HUMANS; LIVER FAILURE, ACUTE; MALE; SERUM ALBUMIN;

EID: 24944449055     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086552     Document Type: Article

References (19)

1. Moreau R, Lebrec D: Acute renal failure in patients with cirrhosis: Perspectives in the age of MELD. Hepatology 2003;37:233-243.
2. Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Scholmerich J: Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis: International Ascites Club. Hepatology 1996;23:164-176.
3. Desmet VJ, De Groote J, Van Damme B: Acute hepatocellular failure: A study of 17 patients treated with exchange transfusion. Hum Pathol 1972;3:167-182.
4. Freeman JG, Matthewson K, Record CO: Plasmapheresis in acute liver failure. Int J Artif Organs 1986;9:433-438.
5. O'Grady JG, Gimson AE, O'Brien CJ, Pucknell A, Hughes RD, Williams R: Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988;94:1186-1192.
6. Falkenhagen D, Strobl W, Vogt G, Schrefl A, Linsberger I, Gerner FJ, Schoenhofen M: Fractionated plasma separation and adsorption system: A novel system for blood purification to remove albumin bound substances. Artif Organs 1999;23:81-86.
7. Gines P, Guevara M, Arroyo V, Rodes J: Hepatorenal syndrome. Lancet 2003;362:1819-1827.
8. Hadengue A, Gadano A, Moreau R, Giostra E, Durand F, Valla D, Erlinger S, Lebrec D: Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol 1998;29:565-570.
9. Cassinello C, Moreno E, Gozalo A, Ortuno B, Cuenca B, Solis-Herrazo JA: Effects of orthotopic liver transplantation on vasoactive systems and renal function in patients with advanced liver cirrhosis. Dig Dis Sci 2003;48:179-186.
10. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR: A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470.
11. Jalan R, Williams R. Acute-on-chronic liver failure: Pathophysiological basis of therapeutic options. Blood Purif 2002;20:252-261.
12. Stange J, Mitzner SR, Ramlow W, Gliesche T, Hickstein H, Schmidt R: A new procedure for the removal of protein bound drugs and toxins. ASAIO J 1993;39:M621-M625.
13. Stange J, Hassanein TI, Mehta R, Mitzner SR, Bartlett RH: The molecular adsorbents recycling system as a liver support system based on albumin dialysis: A summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artif Organs 2002;26:103-110.
14. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchard W, Peszynski P, Freytag J, Hickstein H, Loock J, Loehr JM, Liebe S, Emmrich J, Korten G, Schmidt R: Improvement of hepatorenal syndrome with extracorporeal albumin dialysis - MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transplant 2000;6:277-286.
15. Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, Klammt S, Loehr M, Liebe S, Mitzner S, Schmidt R, Stange J: Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study. Hepatology 2002;36:949-958.
16. Gueler F, Gwinner W, Schiborr C, Martin M, Klos A, Kirsch T, Fiebeler A, Haller H, Fliser D: Biocompatibility parameters of different dialysis membranes assessed during systemic inflammation. Blood Purif 2005;23:196-202.
17. Krisper P, Stauber R, Haditsch B, Trauner M, Holzer H, Schneditz D: MARS versus Prometheus: Comparison of effectivity by follow-up of clearance and reduction ratios. J Hepatol 2004;(suppl 1):A216.
18. Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, Haller H, Manns MP, Fliser D: Prometheus - a new extracorporeal system for the treatment of liver failure. J Hepatol 2003;39:984-990.
19. Kjaergard LL, Liu J, Als-Nielsen B, Gluud C: Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: A systematic review. JAMA 2003;289:217-222.